What is it about?
Eltrombopag is a drug used in the treatment of chronic immune thrombocytopenia in children interferes with the measurement of total bilirubin masking the possible hetotoxicity.
Featured Image
Read the Original
This page is a summary of: Eltrombopag interferes with the measurement of plasma total bilirubin in pediatric patients in an automated colorimetric method, Clinical Chemistry and Laboratory Medicine (CCLM), October 2018, De Gruyter,
DOI: 10.1515/cclm-2018-0789.
You can read the full text:
Contributors
The following have contributed to this page
